Barclays »

Palvella Therapeutics Inc Ne shares owned by Barclays

Quarter-by-quarter ownership of Palvella Therapeutics Inc Ne (PVLA) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Palvella Therapeutics Inc Ne

Tip: Access up to 7 years of quarterly data

All positions including Palvella Therapeutics Inc Ne held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Palvella Therapeutics Inc Ne by Barclays

Quarter filed Position value Share count Share price at filing
2025-09-30 $613k 9.8k 62.69
2025-06-30 $274k 12k 22.50
2025-03-31 $999 63 15.87
2024-12-31 $999 63 15.87

More positions owned by Barclays

Microsoft Corporation (MSFT)
SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Fund (QQQ)
NVIDIA Corporation (NVDA)
Ishares Tr Fund (IWM)
Apple (AAPL)
Tesla Opt Put Option (TSLA)
Amazon Opt Call Option (AMZN)
Alphabet Opt Call Option (GOOGL)
Broadcom Opt Call Option (AVGO)
Facebook Inc cl a (META)
Ishares Tr Opt Call Option (HYG)
JPMorgan Chase & Co. (JPM)
Alphabet Opt Put Option (GOOG)
Berkshire Hathaway Inc Del Opt Put Option (BRK.B)

View all positions for Barclays

Top funds holding Palvella Therapeutics Inc Ne

BVF
Suvretta Capital Management
Frazier Life Sciences Management
First Light Asset Management
Vanguard Group
BlackRock
Perceptive Advisors
Woodline Partners
Federated Investors
Point72 Asset Management
Nantahala Capital Management
Goldman Sachs Group
Samsara BioCapital
Fred Alger Management
Geode Capital Management

View all funds holding Palvella Therapeutics Inc Ne